RGEN
USDRepligen Corporation Common Stock
Цена в режиме реального времени
График цен
Ключевые показатели
Рыночные показатели
Открытие
$149.060
Максимум
$151.250
Минимум
$146.000
Объем
0.61M
Фундаментальные показатели компании
Рыночная капитализация
8.3B
Отрасль
Medical Instruments & Supplies
Страна
United States
Статистические данные торговли
Средний объем
0.92M
Биржа
NMS
Валюта
USD
52-недельный диапазон
Связанные новости
Repligen Corporation to Present at Upcoming November Conferences
WALTHAM, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be attending five upcoming
Canaccord Genuity Maintains Hold on Repligen, Raises Price Target to $165
Canaccord Genuity analyst Kyle Mikson maintains Repligen with a Hold and raises the price target from $150 to $165.
Barclays Maintains Overweight on Repligen, Raises Price Target to $175
Barclays analyst Luke Sergott maintains Repligen with a Overweight and raises the price target from $160 to $175.
Repligen Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance
Revenue of $189 million, year-over-year increase of 22% as reported and 18% organic with double-digit reported growth across all franchisesOrders increased sequentially and greater than 20% year-over-yearIncreasing
Repligen to Report Third Quarter 2025 Financial Results
WALTHAM, Mass., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its third quarter 2025 financial results on Tuesday, October 28, 2025. The Company will
Связанные акции
LVS
Las Vegas Sands Corp.
PECO
Phillips Edison & Company Inc.
TVGNW
Tevogen Bio Holdings Inc. Warrant
QRVO
Qorvo Inc.
WES
Western Midstream Partners LP Common Units Representing Limited Partner Interests
Оставаться в курсе
Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.